Experimental infection and protection against ... - TI Pharma
Experimental infection and protection against ... - TI Pharma
Experimental infection and protection against ... - TI Pharma
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
132 Chapter 7<br />
serum at 5% haematocrit in a semi-automated suspension culture system, in the<br />
absence of antibiotics <strong>and</strong> in an atmosphere containing 4% CO2 <strong>and</strong> 3% O2.<br />
Cloning of NF135 was performed in 96-wells plates by limiting dilution [16].<br />
Characterization of NF135.C10 <strong>and</strong> NF54<br />
Genetic identity of NF135.C10 <strong>and</strong> NF54 was defined by PCR <strong>and</strong> microsatellite<br />
mapping. The polymorphic regions of three Pf antigen genes were assessed in a<br />
method adapted from Snounou et al. [17]. Briefly, parasite DNA was isolated<br />
using QIAamp DNA Blood Mini Kit (Qiagen) <strong>and</strong> amplified with thermoperfect<br />
taq polymerase using specific primers for GLURP, MSP1 K1, MSP1 MAD20 <strong>and</strong><br />
MSP2 IC (all primers from Invitrogen). For microsatellite mapping, the repetitive<br />
element rif MS (pfRRM), a polymorphic microsatellite marker [18] was used to<br />
compare NF135.C10 with NF54. The NF135.C10 <strong>and</strong> NF54 genomic DNA used<br />
was derived from respective master cell banks produced in compliance with<br />
cGMPs at Sanaria. PCR amplification was performed using fluorescently labelled<br />
forward primer 5’-TACGTTACATTATGTTTTA-3’ <strong>and</strong> reverse primer 5’-<br />
ATATGTATTGCGCTTTTA-3’. PCR products generated from each sample were<br />
separated by capillary electrophoresis on an Applied Biosystems 3100 Genetic<br />
Analyzer. A spectral image was generated with the Genemapper software V4.0.<br />
with each individual peak in the spectral image representing a PCR product. The<br />
base pair (bp) size of the amplified sequence products gave a pattern<br />
(fingerprint) that was unique to each malaria strain [18, 19]. Sensitivity of<br />
NF135.C10 <strong>and</strong> NF54 to dihydroartemisinin (DHA; SigmaTau), chloroquine<br />
diphosphate salt (Sigma-Aldrich), proguanil (British <strong>Pharma</strong>copia), atovaquone<br />
(GSK) <strong>and</strong> lumefantrine (Novartis) was tested by the Malaria SYBR Green I-<br />
Based Fluorescence Assay in triplicate experiments [20].<br />
Production of NF135.C10 <strong>and</strong> NF54 infected mosquitoes<br />
Gametocyte suspensions of NF135.C10 or NF54 were fed to Anopheles stephensi<br />
mosquitoes reared according to st<strong>and</strong>ard operating procedures as described<br />
previously [21]. To assess the rate of <strong>infection</strong>, salivary gl<strong>and</strong>s of ten mosquitoes<br />
were dissected for each strain to confirm the presence of sporozoites.<br />
Inclusion, <strong>infection</strong> <strong>and</strong> clinical follow-up of volunteers<br />
Volunteers, aged 18-35, were recruited public by advertisement <strong>and</strong> screened at<br />
the Leiden University Medical Centre (LUMC) for eligibility based on medical <strong>and</strong><br />
family history, physical examination <strong>and</strong> general haematological <strong>and</strong><br />
biochemical tests including HIV, hepatitis B <strong>and</strong> hepatitis C serology, urine